Literature DB >> 30168129

Risk of fistula formation and long-term health effects after a benign hysterectomy complicated by organ injury: A population-based register study.

Susanne Hesselman1,2, Lina Bergman1,2, Ulf Högberg1, Maria Jonsson1.   

Abstract

INTRODUCTION: There is a paucity of data on the impact of organ injury on long-term outcomes after a hysterectomy for benign indications. The aim of this study was to investigate fistula formation and patient-reported long-term health outcomes after organ injury at the time of a hysterectomy.
MATERIAL AND METHODS: This was a population-based study of 22 538 women undergoing a hysterectomy between 2000 and 2014 in Sweden. Their medical history, characteristics of their surgery, and patient-reported outcomes were retrieved from Swedish national health and quality registers. Predictors for fistula formation were investigated with logistic regression and are presented as odds ratios with a 95% CI.
RESULTS: Fistulas were reported in 7% of women with organ injuries, compared with 0.4% of those without organ injuries (adjusted odds ratio 15.29 [9.81-23.85]). Laparotomy and postoperative infection were associated with postoperative fistulas. Most of the women reported having better health 1 year after the hysterectomy, but 7% of those with organ injuries and 24% of those with fistulas reported deteriorated health, compared with 2% of women without injuries.
CONCLUSIONS: Organ injury at the time of hysterectomy is associated with the development of fistulas involving the female genital tract and increases the proportion of women reporting deteriorated health 1 year after surgery.
© 2018 Nordic Federation of Societies of Obstetrics and Gynecology.

Entities:  

Mesh:

Year:  2018        PMID: 30168129     DOI: 10.1111/aogs.13450

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  1 in total

1.  Incidental urinary tract injury and the formation of vesicovaginal fistula at the time of hysterectomy for benign indications.

Authors:  Brandy M Butler; Rony A Adam; Ayush Giri
Journal:  Int Urogynecol J       Date:  2022-09-26       Impact factor: 1.932

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.